Trial reportTransactions of the Royal Society of Tropical Medicine and Hygiene2026
Family quality of life and associated factors among people with leprosy or podoconiosis/lymphatic filariasis with visible disabilities and their family members in Ethiopia: a baseline study for a randomized controlled trial.
Trial report in Transactions of the Royal Society of Tropical Medicine and Hygiene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Leprosy, podoconiosis and lymphatic filariasis (LF) cause impairment and disability affecting family quality of life (FQoL). The purpose of this study was to assess and compare FQoL and associated factors in people in Ethiopia with disabilities caused by leprosy, FL or podoconiosis and their family members. A cross-sectional study was conducted in the East and West Gojjam Zones of Ethiopia. Study participants with visible disabilities were selected by simple random sampling; however, family members were selected purposively. Data were collected using the FQoL, SARI, PHQ-9 and Participation Scale. Descriptive statistics and linear regression were used to analyse the data. These findings are based on baseline data collected before the intervention phase of a randomized controlled trial. A total of 416 people with disabilities and 416 family members participated in the study. The overall mean FQoL score for both groups was 75.4. Among people with disabilities, FQoL was significantly associated with increasing age (β=0.045, p<0.001), disease type (leprosy, β=0.561, p<0.029), stigma (β=-0.274, p<0.001) and participation restriction (β=-0.740, p<0.001). For family members, disease type (leprosy, β=3.910, p<0.001), student or unpaid work (β=3.640, p<0.001), marital status (single, β=1.803, p<0.033) and residence (rural, β=3.160, p<0.002) showed a significant association with FQoL. To improve FQoL, a targeted family-based care package should address challenges related to age, disease type, stigma and participation restrictions of people with disabilities as well as the sociodemographic factors affecting their family members.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.